Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:ALXA

ALXA (ALXA) Stock Price, News & Analysis

ALXA logo

About ALXA Stock (OTCMKTS:ALXA)

Advanced Chart

Key Stats

Today's Range
$0.94
$0.94
50-Day Range
N/A
52-Week Range
$0.22
$1.60
Volume
100 shs
Average Volume
158,340 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients with acute repetitive seizures, and AZ-007, which contains zaleplon as API is developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients with middle of the night awakening having difficulty falling back asleep. Its product also includes ADASUVE, which contains loxapine as API is developed for the treatment of agitation associated with schizophrenia or bipolar disorder. It has initiated a Phase IIa proof-of-concept study for AZ-002 in patients with epilepsy and has completed Phase I testing for AZ-007.

Receive ALXA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALXA and its competitors with MarketBeat's FREE daily newsletter.

ALXA Stock News Headlines

Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Amazon CEO says 100,000 users now have Alexa+
Susan Solves It: Alexa Privacy Concerns
Alexa, Hear me out!
See More Headlines

ALXA Stock Analysis - Frequently Asked Questions

ALXA (OTCMKTS:ALXA) released its earnings results on Wednesday, May, 11th. The healthcare company reported ($0.16) earnings per share for the quarter. The healthcare company had revenue of $0.72 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that ALXA investors own include Anavex Life Sciences (AVXL), Pernix Therapeutics (PTX), BioDelivery Sciences International (BDSI), PayPal (PYPL), Achillion Pharmaceuticals (ACHN), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Company Calendar

Last Earnings
5/11/2016
Today
5/06/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:ALXA
Previous Symbol
NASDAQ:ALXA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:ALXA) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners